Αρχική World News Hormone Therapy Can Put Cancer Cells Into Sleep Mode And Cause A...

Hormone Therapy Can Put Cancer Cells Into Sleep Mode And Cause A Relapse Years Afterwards

Breast cancer cells are able to go into “sleep mode” and lie dormant until they are triggered into action again, researchers out of Imperial College London found.The trigger? Hormone treatments.“For a long time, scientists have debated whether hormone therapies – which are a very effective treatment and save millions of lives – work by killing breast cancer cells or whether the drugs flip them into a dormant ‘sleeper’ state,” said Dr. Luca Magnani, the author of the study who’s a doctor in Imperial’s Department of Surgery and Cancer.“This is an important question as hormone treatments are used on the majority of breast cancers,” she continued. “Our findings suggest the drugs may kill some cells and switch others into this sleeper state. If we can unlock the secrets of these dormant cells, we may be able to find a way of preventing cancer coming back, either by holding the cells in permanent sleep mode, or be waking them up and killing them.”Photo: Adobe Stock/fizkes
Hormone therapy is often used to treat breast cancers that are estrogen-receptor positive (ER+). Over 70% of breast cancers are ER+. Since these cancer cells are fueled by estrogen, hormone therapy deploys blockers for their estrogen receptors, which starves the cancer cells and kills them.However, hormone therapy isn’t without its downside. Roughly 30% of breast cancer patients who undergo hormone therapies experience a recurrence or relapse of their breast cancer. Recurrence can happen shortly after treatment ends, or years later. And when the cancer returns, it is often metastatic and more aggressive than before. Metastatic cancer (also called stage IV) is cancer that has travelled from the origin site to other areas of the body, such as the the brain, liver, lungs, or bones.Recurring breast cancer can also be resistant to treatments.Photo: Adobe Stock/vitanovski
This study on hormone therapy and breast cancer cells was published in the journal Nature Communications and led by a team of researchers at the Imperial College London.The team studied 50,000 human breast cancer cells in the lab. When they used hormone therapy on the cells, some of the cells were found to be in a “dormant” state. The therapy didn’t destroy them or leave them untouched — instead, they essentially put them to sleep.Researchers also found that these dormant cancer cells were more likely to metastasize to other parts of the body.“Our experiments suggest these sleeper cells are more likely to travel around the body,” said Dr Sung Pil Hong, one of the study’s co-authors. “They could then ‘awaken’ once in other organs of the body, and cause secondary cancers.”Photo: Adobe Stock/arcyto
In a previous study, this same group of researchers found a possible reason why the breast cancer cells become resistant to hormone therapy; some cancer cells were able to create their own “fuel” and therefore didn’t rely solely on estrogen to survive and couldn’t be starved by treatments.The most recent study offered additional insight into why this could be: cells in this dormant stage were triggered by the cancer drugs themselves. They shut down but didn’t die, and were able to be reawakened later.“These sleeper cells seem to be an intermediate stage to the cells becoming resistant to the cancer drugs,” said Dr. Iros Barozzi, one of the the study’s co-authors. “The findings also suggest the [cancer] drugs trigger the cancer cells to enter this sleeper state.”Photo: Adobe Stock/science photo
Despite their findings, the research team underscored the value and effectiveness of hormone therapy treatments for breast cancer, and emphasized that it’s one of the most effective treatments for the disease.Further research on these sleeper cells could give us more clarity on why breast cancer cells become resistant to some treatments.“We still don’t know how these cells switch themselves into sleep mode – and what would cause them to wake up. These are questions that need to be addressed with further research,” said Dr. Barozzi and Dr. Hong.Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...

Καρκίνος: Ευεργετική για τους καρκινοπαθείς η άσκηση

Σημαντικά ωφέλη προσφέρει η άσκηση, ακόμη και σε ασθενείς με καρκίνο. Οι περισσότεροι ασθενείς αγνοούν τα οφέλη που μπορεί να έχει γι’ αυτούς η συχνή...

Prostate Cancer

The article is provided by Scientific Communications Officer of NIPD Genetics, Ms Marina Charitou (MSc) Prostate Cancer Awareness Prostate cancer is the second most common cancer...
- Advertisment -

Ροή Ειδήσεων

An existing blood test for ovarian cancer has been re-evaluated. The results are in.

Ovarian cancer is the sixth most common cancer in women in the UK, with about 7,400 new cases every year. This number equates to...

How to Stay Healthy After Cancer

I try to pack helpful advice into every follow-up visit I have with patients, focusing on little tips that help foster healthy lifestyles. This...

Feasibility and Preliminary Efficacy Results of the Beat AML Study

Precision medicine in acute myeloid leukaemia (AML) is feasible in terms of providing cytogenetic and mutational data within 7 days, allowing their rapid incorporation into...

Woman Battles Breast Cancer While Pregnant, Delivers Healthy Baby Boy

When she was six months pregnant, Desiree Doughty noticed that something seemed to be wrong with her breasts. “I noticed that one of my breasts...

Pumpkin Season!

Halloween may look different this year but we can still decorate our homes and enjoy a favorite fall treat – pumpkin and pumpkin seeds....

ACHIEVE-2 Results of Oxaliplatin-Based Adjuvant Chemotherapy in Asian Patients with High-Risk Stage II Colon Cancer

The Asian researchers reported on 25 October 2020 in the Annals of Oncology that 3-month of combination therapy for adjuvant treatment of high-risk stage...